Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Top Cited Papers
- 7 April 2009
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 15 (4), 294-303
- https://doi.org/10.1016/j.ccr.2009.02.022
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanomaPathology, 2007
- Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsJournal of Medical Genetics, 2006
- Cellular senescence in naevi and immortalisation in melanoma: a role for p16?British Journal of Cancer, 2006
- Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma ModelsCancer Research, 2006
- Expression of Endogenous OncogenicV600EB-rafInduces Proliferation and Developmental Defects in Mice and Transformation of Primary FibroblastsCancer Research, 2005
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma caseMelanoma Research, 2003
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Acquired Precursors of Cutaneous Malignant MelanomaThe New England Journal of Medicine, 1985